91 related articles for article (PubMed ID: 8638548)
1. High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Di Costanzo F; Tagliaventi M; Carlini P; Zironi S; Mazzocchi B; Bella M; Donati D; Acito L; Maggian P; Angiona S
Am J Clin Oncol; 1996 Jun; 19(3):307-10. PubMed ID: 8638548
[TBL] [Abstract][Full Text] [Related]
2. 5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial.
Sdrobolini A; Contu A; Massidda B; Gasperoni S; Recchia F; Iannelli A; Tomao S; Romiti A; Raffaele M; Ortu S; Campisi C; Gebbia V; Olmeo N; Ionta MT; Angiona S; Di Costanzo F
Tumori; 2000; 86(3):211-4. PubMed ID: 10939601
[TBL] [Abstract][Full Text] [Related]
3. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F; Bartolucci R; Calabresi F; Sofra M; Marzola M; Belsanti V; Boni C; Bacchi M
Ann Oncol; 1992 May; 3(5):371-6. PubMed ID: 1616890
[TBL] [Abstract][Full Text] [Related]
4. High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
Di Costanzo F; Gasperoni S; Malacarne P; Belsanti V; Luppi G; Marzola M; Corgna E; Sdrobolini A; Passalacqua R; Figoli F; Algeri R; Zironi S; Angiona S; Boni C
Am J Clin Oncol; 1998 Aug; 21(4):369-75. PubMed ID: 9708636
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.
Caudry M; Bonnel C; Floquet A; Marsault C; Quétin P; Pujol J; Maton O; Dujols JP; Caudry Y; Skawinski P
Am J Clin Oncol; 1995 Apr; 18(2):118-25. PubMed ID: 7900703
[TBL] [Abstract][Full Text] [Related]
6. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
8. Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas.
Poorter RL; Bakker PJ; Huizing MT; Taat CW; Rietbroek RC; Gouma DJ; Rauws EA; Veenhof CH
Ann Oncol; 1995 Dec; 6(10):1048-9. PubMed ID: 8750159
[TBL] [Abstract][Full Text] [Related]
9. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
[TBL] [Abstract][Full Text] [Related]
11. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Ducreux M; Van Cutsem E; Van Laethem JL; Gress TM; Jeziorski K; Rougier P; Wagener T; Anak O; Baron B; Nordlinger B;
Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
[TBL] [Abstract][Full Text] [Related]
12. Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F; Canaletti R; Sdrobolini A; Olmeo N; Luppi G; Pucci F; Cavicchi F; Gasperoni S; Rodinò C; Zironi S; Angiona S; Contu A
Am J Clin Oncol; 2000 Jun; 23(3):314-8. PubMed ID: 10857901
[TBL] [Abstract][Full Text] [Related]
13. Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative study.
Tsavaris N; Tentas K; Tzivras M; Kosmas C; Kalachanis N; Katsikas M; Dimitrakopoulos A; Papastratis G; Macheras A; Karatzas G; Sechas M
J Chemother; 1998 Aug; 10(4):331-7. PubMed ID: 9720474
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
15. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
Jäger E; Klein O; Wächter B; Bernhard H; Dippold W; Meyer zum Büschenfelde KH; Knuth A
Oncology; 1996; 53(1):58-63. PubMed ID: 8570133
[TBL] [Abstract][Full Text] [Related]
16. High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancer.
Scholnik AP; Arnold DJ; Walker WS; Schwenke P; Suhrland LG; Balcueva EP; Dimitrov NV
Am J Clin Oncol; 1988 Oct; 11(5):558-63. PubMed ID: 3263037
[TBL] [Abstract][Full Text] [Related]
17. Folinic acid does improve 5-fluorouracil activity in vivo. Results of a phase III study comparing 5-fluorouracil to 5-fluorouracil and folinic acid in advanced colon cancer patients.
Bobbio-Pallavicini E; Porta C; Moroni M; Spaghi A; Casagranda I; Nastasi G
J Chemother; 1993 Feb; 5(1):52-5. PubMed ID: 8459266
[TBL] [Abstract][Full Text] [Related]
18. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
Erlichman C; Fine S; Wong A; Elhakim T
J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
[TBL] [Abstract][Full Text] [Related]
20. Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Lutz MP; Wilke H; Wagener DJ; Vanhoefer U; Jeziorski K; Hegewisch-Becker S; Balleisen L; Joossens E; Jansen RL; Debois M; Bethe U; Praet M; Wils J; Van Cutsem E; ;
J Clin Oncol; 2007 Jun; 25(18):2580-5. PubMed ID: 17577037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]